{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:07:14Z","timestamp":1790690834801,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009828","name":"Cancer Research Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000866","name":"Cardiff University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015570","name":"Blood Cancer UK","doi-asserted-by":"publisher","award":["15038"],"award-info":[{"award-number":["15038"]}],"id":[{"id":"10.13039\/501100015570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015570","name":"Blood Cancer UK","doi-asserted-by":"publisher","award":["19007"],"award-info":[{"award-number":["19007"]}],"id":[{"id":"10.13039\/501100015570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C7838\/A25173"],"award-info":[{"award-number":["C7838\/A25173"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bneo.2026.100259","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:34:27Z","timestamp":1781778867000},"page":"100259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression of RUNX1::RUNX1T1 deregulates the proteome, induces C\/EBP\u03b2 suppression, and blocks myeloid differentiation"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2280-9483","authenticated-orcid":false,"given":"Aleksandra","family":"Azevedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8350-6095","authenticated-orcid":false,"given":"Adam","family":"Leckenby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5304-9498","authenticated-orcid":false,"given":"Rachael","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Catarina","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2236-8852","authenticated-orcid":false,"given":"Amanda F.","family":"Gilkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7474-9757","authenticated-orcid":false,"given":"Sarah","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Toghill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9319-8738","authenticated-orcid":false,"given":"Ellie","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5592-5532","authenticated-orcid":false,"given":"Bethany","family":"Geary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Whetton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Darley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-4976","authenticated-orcid":false,"given":"Alex","family":"Tonks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.bneo.2026.100259_bib2","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","article-title":"DNMT3A mutations in acute myeloid leukemia","volume":"363","author":"Ley","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.bneo.2026.100259_bib3","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1182\/blood.V91.9.3134","article-title":"Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors","volume":"91","author":"Okuda","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bneo.2026.100259_bib4","article-title":"Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications","volume":"2011","author":"Reikvam","year":"2011","journal-title":"J Biomed Biotechnol"},{"issue":"2","key":"10.1016\/j.bneo.2026.100259_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020641","article-title":"Targeted therapy development in acute myeloid leukemia","volume":"11","author":"Totiger","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bneo.2026.100259_bib6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41467-024-45691-4","article-title":"Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth","volume":"15","author":"Kellaway","year":"2024","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.bneo.2026.100259_bib7","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/sj.leu.2403396","article-title":"Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal","volume":"18","author":"Tonks","year":"2004","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bneo.2026.100259_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood.V99.1.15","article-title":"The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells","volume":"99","author":"Mulloy","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bneo.2026.100259_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2002-06-1732","article-title":"The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cells","volume":"101","author":"Tonks","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bneo.2026.100259_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/86515","article-title":"AML1-ETO downregulates the granulocytic differentiation factor C\/EBPalpha in t(8;21) myeloid leukemia","volume":"7","author":"Pabst","year":"2001","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.bneo.2026.100259_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2002-04-1288","article-title":"The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia","volume":"101","author":"Vangala","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bneo.2026.100259_bib12","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1038\/sj.leu.2404961","article-title":"Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia","volume":"21","author":"Tonks","year":"2007","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.bneo.2026.100259_bib13","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1172\/JCI17595","article-title":"Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair","volume":"112","author":"Alcalay","year":"2003","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.bneo.2026.100259_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41375-019-0596-4","article-title":"Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia","volume":"34","author":"Alanazi","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bneo.2026.100259_bib15","article-title":"Global variability analysis of mRNA and protein concentrations across and within human tissues","volume":"2","author":"Wegler","year":"2020","journal-title":"NAR Genom Bioinform"},{"issue":"5","key":"10.1016\/j.bneo.2026.100259_bib16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.leukres.2011.11.024","article-title":"Proteomic analysis identifies differentially expressed proteins in AML1\/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine","volume":"36","author":"Buchi","year":"2012","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.bneo.2026.100259_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12014-010-9051-2","article-title":"Proteomics of AML1\/ETO target proteins: AML1\u2013ETO targets a C\/EBP\u2013NM23 pathway","volume":"6","author":"Singh","year":"2010","journal-title":"Clin Proteomics"},{"issue":"1","key":"10.1016\/j.bneo.2026.100259_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41467-017-00249-5","article-title":"Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry","volume":"8","author":"Collins","year":"2017","journal-title":"Nat Commun"},{"issue":"21","key":"10.1016\/j.bneo.2026.100259_bib19","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1182\/bloodadvances.2020002891","article-title":"CD34 expression does not correlate with immunophenotypic stem cell or progenitor content in human cord blood products","volume":"4","author":"Mantri","year":"2020","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.bneo.2026.100259_bib20","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41375-022-01577-2","article-title":"Increased expression of RUNX3 inhibits normal human myeloid development","volume":"36","author":"Menezes","year":"2022","journal-title":"Leukemia"},{"issue":"14","key":"10.1016\/j.bneo.2026.100259_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143557","article-title":"NF-kB: a druggable target in acute myeloid leukemia","volume":"14","author":"Di Francesco","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"13","key":"10.1016\/j.bneo.2026.100259_bib22","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1182\/blood-2008-03-147207","article-title":"CBFbeta is critical for AML1-ETO and TEL-AML1 activity","volume":"113","author":"Roudaia","year":"2009","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.bneo.2026.100259_bib23","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/bloodadvances.2018022913","article-title":"C\/EBP\u03b2 isoforms sequentially regulate regenerating mouse hematopoietic stem\/progenitor cells","volume":"4","author":"Sato","year":"2020","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.bneo.2026.100259_bib24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/ni1354","article-title":"C\/EBPbeta is required for 'emergency' granulopoiesis","volume":"7","author":"Hirai","year":"2006","journal-title":"Nat Immunol"},{"issue":"Pt 3","key":"10.1016\/j.bneo.2026.100259_bib25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/bj20020508","article-title":"CCAAT\/enhancer-binding proteins: structure, function and regulation","volume":"365","author":"Ramji","year":"2002","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.bneo.2026.100259_bib26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/152581601753193841","article-title":"Ectopic expression of CCAAT\/enhancer binding protein beta (C\/EBPbeta) in long-term bone marrow cultures induces granulopoiesis and alters stromal cell function","volume":"10","author":"Popernack","year":"2001","journal-title":"J Hematother Stem Cell Res"},{"issue":"D1","key":"10.1016\/j.bneo.2026.100259_bib27","doi-asserted-by":"crossref","first-page":"D917","DOI":"10.1093\/nar\/gkv1101","article-title":"BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis","volume":"44","author":"Bagger","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"10.1016\/j.bneo.2026.100259_bib28","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1101\/gad.14.15.1920","article-title":"Translational control of C\/EBPalpha and C\/EBPbeta isoform expression","volume":"14","author":"Calkhoven","year":"2000","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.bneo.2026.100259_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4161\/cc.3.4.789","article-title":"A new role for C\/EBPbeta in acute promyelocytic leukemia","volume":"3","author":"Duprez","year":"2004","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.bneo.2026.100259_bib57","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1182\/blood-2013-02-485771","article-title":"Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients","volume":"123","author":"Rapin","year":"2014","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.bneo.2026.100259_bib30","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bneo.2026.100259_bib31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2141.2009.08012.x","article-title":"ITD- and FL-induced FLT3 signal transduction leads to increased C\/EBPbeta-LIP expression and LIP\/LAP ratio by different signalling modules","volume":"148","author":"Haas","year":"2010","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.bneo.2026.100259_bib32","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2005-10-014258","article-title":"NPM-ALK-dependent expression of the transcription factor CCAAT\/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma","volume":"108","author":"Quintanilla-Martinez","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bneo.2026.100259_bib33","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/sj.onc.1202459","article-title":"The t(8;21) fusion protein, AML1\/ETO, transforms NIH3T3 cells and activates AP-1","volume":"18","author":"Frank","year":"1999","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bneo.2026.100259_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.08.040","article-title":"RUNX1-ETO depletion in t(8;21) AML leads to C\/EBP\u03b1- and AP-1-mediated alterations in enhancer-promoter interaction","volume":"28","author":"Ptasinska","year":"2019","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.bneo.2026.100259_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.08.015","article-title":"The oncogenic transcription factor RUNX1\/ETO corrupts cell cycle regulation to drive leukemic transformation","volume":"34","author":"Martinez-Soria","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bneo.2026.100259_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/srep35391","article-title":"Application of targeted mass spectrometry for the quantification of sirtuins in the central nervous system","volume":"6","author":"Jayasena","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bneo.2026.100259_bib37","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409001033","article-title":"CCAAT\/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases","volume":"11","author":"Zahnow","year":"2009","journal-title":"Expert Rev Mol Med"},{"issue":"3","key":"10.1016\/j.bneo.2026.100259_bib38","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0092-8674(91)90531-3","article-title":"A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA","volume":"67","author":"Descombes","year":"1991","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.bneo.2026.100259_bib39","doi-asserted-by":"crossref","first-page":"22716","DOI":"10.1074\/jbc.M110.152538","article-title":"CCAAT\/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein\/E2F\/cyclin E pathway but is not directly required for macrophage morphology","volume":"286","author":"Gutsch","year":"2011","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.bneo.2026.100259_bib40","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1182\/blood-2002-03-0835","article-title":"The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow","volume":"101","author":"Bjerregaard","year":"2003","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.bneo.2026.100259_bib41","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1093\/emboj\/cdg556","article-title":"C\/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells","volume":"22","author":"Duprez","year":"2003","journal-title":"EMBO J"},{"issue":"6","key":"10.1016\/j.bneo.2026.100259_bib42","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood.V99.6.2032","article-title":"Expression of C\/EBPbeta from the C\/ebpalpha gene locus is sufficient for normal hematopoiesis in vivo","volume":"99","author":"Jones","year":"2002","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bneo.2026.100259_bib43","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2005-07-3068","article-title":"ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression","volume":"107","author":"Mueller","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bneo.2026.100259_bib44","article-title":"A direct comparison between AML1-ETO and ETO2-GLIS2 leukemia fusion proteins reveals context-dependent binding and regulation of target genes and opposite functions in cell differentiation","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"28","key":"10.1016\/j.bneo.2026.100259_bib45","doi-asserted-by":"crossref","first-page":"16477","DOI":"10.1074\/jbc.271.28.16477","article-title":"CAAT\/enhancer-binding proteins are involved in beta-globin gene expression and are differentially expressed in murine erythroleukemia and K562 cells","volume":"271","author":"Wall","year":"1996","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.bneo.2026.100259_bib46","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1182\/blood-2005-08-3181","article-title":"Inducible activation of CEBPB, a gene negatively regulated by BCR\/ABL, inhibits proliferation and promotes differentiation of BCR\/ABL-expressing cells","volume":"107","author":"Guerzoni","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bneo.2026.100259_bib47","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood-2007-04-087213","article-title":"Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C\/EBPbeta-deficient hematopoietic cells","volume":"111","author":"Akagi","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bneo.2026.100259_bib48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.stem.2012.01.007","article-title":"Infection-responsive expansion of the hematopoietic stem and progenitor cell compartment in zebrafish is dependent upon inducible nitric oxide","volume":"10","author":"Hall","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.bneo.2026.100259_bib49","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/j.1460-2075.1993.tb05852.x","article-title":"Synergistic activation of the chicken mim-1 gene by v-myb and C\/EBP transcription factors","volume":"12","author":"Burk","year":"1993","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/j.bneo.2026.100259_bib50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4161\/cc.5.9.2733","article-title":"Stop and go: anti-proliferative and mitogenic functions of the transcription factor C\/EBPbeta","volume":"5","author":"Sebastian","year":"2006","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.bneo.2026.100259_bib51","first-page":"156","article-title":"Impaired generation of bone marrow B lymphocytes in mice deficient in C\/EBPbeta","volume":"90","author":"Chen","year":"1997","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.bneo.2026.100259_bib52","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2017-03-772962","article-title":"C\/EBP\u03b2 is required for survival of Ly6C- monocytes","volume":"130","author":"Tamura","year":"2017","journal-title":"Blood"},{"issue":"29","key":"10.1016\/j.bneo.2026.100259_bib53","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1038\/s41388-021-01800-x","article-title":"C\/EBP\u03b2 is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia","volume":"40","author":"Yusenko","year":"2021","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bneo.2026.100259_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124308","article-title":"The \"Janus\" role of C\/EBPs family members in cancer progression","volume":"21","author":"Tolomeo","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.bneo.2026.100259_bib55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0092-8674(95)90418-2","article-title":"Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages","volume":"80","author":"Tanaka","year":"1995","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bneo.2026.100259_bib56","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.4049\/jimmunol.160.5.2334","article-title":"Redundancy of C\/EBP alpha, -beta, and -delta in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1","volume":"160","author":"Hu","year":"1998","journal-title":"J Immunol"},{"issue":"D1","key":"10.1016\/j.bneo.2026.100259_bib1","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:17:47Z","timestamp":1790687867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328026000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2950328026000701"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100259","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of RUNX1::RUNX1T1 deregulates the proteome, induces C\/EBP\u03b2 suppression, and blocks myeloid differentiation","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100259"}}